ENTITY

Starton Holdings (STA US)

2
Analysis
Health Care • United States
Starton Holdings, Inc. is a clinical-stage biotechnology company that uses its proprietary continuous delivery technology platform to improve standard-of-care cancer therapies. The company is conducting an initial public offering to fund the development of its lead product candidates, STAR-LLD, which are continuous delivery systems of lenalidomide for various hematologic malignancies.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x